Talis Biomedical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Talis Biomedical using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-14 | $-8.62 | $-7.37 | -17.0 % |
Jun 2023 | 2023-08-10 | $-8.27 | $-8.25 | -0.24 % |
Mar 2023 | 2023-05-11 | $-9.90 | $-10.95 | 9.59 % |
Dec 2022 | 2023-03-22 | $-15.15 | $-10.20 | -48.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-14 | $140.00K | $100.00K | 40.0 % |
Mar 2023 | 2023-05-11 | $1.22M | $250.00K | 387.2 % |
Dec 2022 | 2023-03-22 | $257.00K | $800.00K | -67.9 % |
Sep 2022 | 2022-11-03 | $796.00K | $600.00K | 32.7 % |
Talis Biomedical (TLIS) is scheduled to report earnings on November 26, 2024. The last reported earnings were for reported on August 19, 2024 for Q2.
The Actual EPS was $-4.86, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.